Jefferies Cuts Price Target on Immune Design (IMDZ) to $15 Following 3Q
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- AMC Entertainment (AMC) Enters $250M ATM Agreement
Immune Design (IMDZ) Tops Q3 EPS by 11c
November 9, 2016 4:48 PM ESTImmune Design (NASDAQ: IMDZ) reported Q3 EPS of ($0.60), $0.11 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $1.73 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... MoreTrading Radar for 11/9: Viacom (VIAB), Shake Shack (SHAK), TASER (TASR), Crocs (CROX), SunPower (SPWR) Report
November 8, 2016 3:12 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AdvancePierre Foods Holdings (Nasdaq: APFH) - consensus EPS $0.48
AgroFresh Solutions (Nasdaq: AGFS) - consensus EPS $0.12
Antares Pharma (Nasdaq: ATRS) - consensus loss $0.03
Arctic Cat (Nasdaq: ACAT) - consensus EPS $0.36
Barrett Business Services (Nasdaq: BBSI) - no Street consensus
Bellatrix Exploration (NYSE:... More